The Monash Alfred Psychiatry Research Center (MAPrc) is conducting an observational research study into the use and effect of antipsychotic medications in pregnancy and breastfeeding. Women can join the study anytime between conception and up to 12 months postpartum. Participants will be contacted at the antenatal (at each trimester) and postnatal (at 6 weeks and each trimester) stages via telephone, email and/or face to face interviews. Each interview will last 30-60 minutes. Pregnancy information will be collected retrospectively for those participants who join the study postpartum. The collected data includes medical history, diagnosis, symptoms and medications; obstetric history and outcomes of delivery; parental attachment and parenting heath; and the child’s health and wellbeing.

MAPrc has a Perinatal Psychiatry clinic on site, where women who become/or wish to become pregnant can receive an advice (second opinion) regarding their medication. Study participants will have an opportunity to access this service if they so wish.

To find out more or to get in touch with our team, click the link below or contact us on (03) 9076 6591. Ethics Committee Project Number: 422/18.

Monash Alfred Psychiatry Research Centre Vision, Track Record & Research

Our vision is to develop effective new treatments and new understanding for men and women with mental illness. Our internationally recognised team is made up of passionate researchers and clinicians from diverse backgrounds, including psychiatry, endocrinology, neuropsychology , molecular biology and nursing.

Our Track Record We have published over 200 scientific papers, authored national and international clinical practice and research guidelines and obtained multiple NHMRC and ARC grants.

Our Research Across the team we are currently conducting 22 research projects, including 5 clinical treatment trials, a number of student projects as well as a Specialised Women’s Mental Health and Perinatal Psychiatry Clinics.